Israel, Feb. 7 -- based UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence (AI), has announced a partnership with Selvas Healthcare (subsidiary of Selvas Group), a Korean-based global digital healthcare company with innovative technology in medical device manufacturing and software.

This new joint venture kicks off the introduction of UltraSight's real-time AI guidance technology in Asia, beginning with the regulatory process for approvals that may lead to eventual commercialization and distribution in Korea and the Southeast Asian market.

UltraSight CEO Davidi Vortman said, "We aim to address the significant global disparity between the number of cardiovascular disease patient...